Shopping Cart
- Remove All
- Your shopping cart is currently empty
Irpagratinib (ABSK011) is an orally active and highly effective FGFR4 antagonist with antitumor activity, inhibiting FGFR4 autophosphorylation and blocking FGFR4 signaling to downstream pathways. It is used in studies of gastrointestinal diseases and cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $538 | In Stock | |
5 mg | $1,330 | In Stock | |
10 mg | $2,150 | In Stock | |
25 mg | $3,970 | In Stock | |
50 mg | $5,760 | In Stock | |
1 mL x 10 mM (in DMSO) | $1,690 | In Stock |
Description | Irpagratinib (ABSK011) is an orally active and highly effective FGFR4 antagonist with antitumor activity, inhibiting FGFR4 autophosphorylation and blocking FGFR4 signaling to downstream pathways. It is used in studies of gastrointestinal diseases and cancer. |
Targets&IC50 | FGFR4:< 10 nM |
In vitro | Irpagratinib inhibits FGFR4 with IC50 < 10 nM and shows at least 50-fold selectivity against other FGFR kinases. Irpagratinib has the ability to irreversibly modify Cys552. [1] |
In vivo | Oral Irpagratinib strongly inhibited the growth of subcutaneous xenograft tumors dependent on FGFR4 activity and induced their regression. [1] |
Alias | ABSK011, ABSK 011 |
Molecular Weight | 570.59 |
Formula | C28H32F2N6O5 |
Cas No. | 2230974-62-4 |
Smiles | N(C1=NC=2C(=NC(=CC2C=N1)C3=C(F)C(OC)=CC(OC)=C3F)N4CC(OC)(C)C4)[C@H]5[C@@H](NC(C=C)=O)CCOC5 |
Storage | store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (140.21 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.